Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
NewYork–Presbyterian Hospital · Columbia University Irving Medical Center · +13 more institutions
Abstract
Many patients with severe aortic stenosis and coexisting conditions are not candidates for surgical replacement of the aortic valve. Recently, transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for high-risk patients with aortic stenosis.
We randomly assigned patients with severe aortic stenosis, whom surgeons considered not to be suitable candidates for surgery, to standard therapy (including balloon aortic valvuloplasty) or transfemoral transcatheter implantation of a balloon-expandable bovine pericardial valve. The primary end point was the rate of death from any cause.
Citation impact
- FWCI
- 300.77
- Percentile
- 100%
- References
- 43
Authors
22- MBMartin B. LeonCorresponding
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
- CRCraig R. Smith
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
- MJMichael J. Mack
Medical City Dallas Hospital
- DCD. Craig Miller
Stanford University
- JWJeffrey W. Moses
NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, New York Hospital Queens
Topics & keywords
- Medicine
- Stenosis
- Aortic valve replacement
- Cardiology
- Internal medicine
- Aortic valve stenosis
- Aortic valve
- Surgery
- Good health and well-being